Going wide on immune system activation, with Jeffrey Meckler

Indaptus CEO Jeff Meckler discusses his company's unconventional approach to immunotherapy, based on activating a wide swath of the immune system.

Modelling biologics: Challenges and opportunities, with Dr D...

From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.

Supercharging clinical development with RWE – with Recursion...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.

John ‘Chip’ Scarlett Reveals Rytelo’s Blockbuster Potential ...

Jennifer Schneider’s insights on immunotherapy at JP Morgan ...

Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference